secwatch.observer — SEC 8-K summary
======================================

Issuer:     Actinium Pharmaceuticals, Inc. (ATNM)
CIK:        0001388320
Form:       8-K
Filed at:   2025-11-26T23:59:59+00:00
Accession:  0001213900-25-115586
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Actinium re-elects Shetty and Almenoff as Class III directors at 2025 annual meeting
--------------------------------------------------------------------------------

- Shetty elected with 5,032,369 for, 1,234,852 withheld; Almenoff with 5,284,503 for, 982,719 withheld.
- Ratification of CBIZ as auditor: 13,724,478 for, 1,537,998 against, 232,097 abstain.
- Non-binding advisory vote on executive compensation approved: 4,481,875 for, 1,541,460 against.
- Advisory vote on frequency of say-on-pay: 1-year interval received most votes (4,645,270).
- Total shares present: 15,494,573 of 31,195,891 outstanding; all proposals approved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1388320/000121390025115586/0001213900-25-115586-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1388320/000121390025115586/ea026750301-8k_actinium.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-115586

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer